NBIX Competitors & Alternatives

Compare Neurocrine Biosciences Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

NBIX

Main Stock
$156.22
Tradestie Score
60
Market Cap
$13.59B
P/E Ratio
22.7
Revenue Growth
0.4%
Analyst Upside
+35.5%

Top Competitors

45 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
TEVA Teva Pharmaceutical Industries Limited American Depositary Shares
$37.09
$23.01B 61.6 44 Compare
UTHR United Therapeutics Corp
$497.11
$19.82B 18.0 47 Compare
INCY Incyte Genomics Inc
$121.47
$16.93B 16.1 50 Compare
HIMS Hims & Hers Health, Inc.
$27.51
$12.73B - 48 Compare
RDY Dr. Reddy's Laboratories Limited American Depositary Shares
$11.90
$11.82B 28.6 46 Compare
VTRS Viatris Inc. Common Stock
$16.51
$11.76B - 54 Compare
BMRN BioMarin Pharmaceuticals Inc
$65.68
$10.53B 177.1 58 Compare
ELAN Elanco Animal Health Incorporated Common Stock
$23.17
$10.33B - 39 Compare
RGC Regencell Bioscience Holdings Limited Ordinary Shares
$5.64
$7.83B - 45 Compare
ALKS Alkermes Inc. plc
$45.97
$5.06B 118.2 59 Compare

Data updated: Sep 13, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2836)

45 stocks in this industry